share_log

Goldman Sachs Maintains Buy on BrightSpring Health, Lowers Price Target to $23

Goldman Sachs Maintains Buy on BrightSpring Health, Lowers Price Target to $23

高盛维持对BrightSpring Health的买入,将目标股价下调至23美元
Benzinga ·  03/04 09:23

Goldman Sachs analyst Jamie Perse maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and lowers the price target from $26 to $23.

高盛分析师杰米·珀斯维持BrightSpring Health(纳斯达克股票代码:BTSG)的买入并将目标股价从26美元下调至23美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发